Global Retirement Partners’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.7K Hold
47
– – ﹤0.01% 4109
2026
Q2
$2.96K Sell
47
-26
-36% -$1.66K ﹤0.01% 3875
2025
Q4
$5.98K Buy
73
+19
+35% +$1.42K ﹤0.01% 3376
2025
Q3
$3.21K Buy
54
+6
+13% +$295 ﹤0.01% 3145
2025
Q2
$1.94K Buy
+48
New +$2.16K ﹤0.01% 3250
2024
Q4
– Sell
-38
Closed -$1.25K – 3775
2024
Q3
$1.25K Buy
+38
New +$1.07K ﹤0.01% 3089

Other funds holding TARS

Global Retirement Partners's TARS Position: Q3 2026 in Review

Global Retirement Partners held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2026 at 47 shares worth $3.7K. The position accounts for ﹤0.01% of the portfolio, ranked #4109.

Global Retirement Partners first reported a position in TARS in Q3 2024 and has held it in 6 quarters since. The position peaked at $5.98K in Q4 2025. 255 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Global Retirement Partners held 47 shares of Tarsus Pharmaceuticals worth $3.7K as of Q3 2026.
  • Global Retirement Partners left its Tarsus Pharmaceuticals share count unchanged in Q3 2026.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Global Retirement Partners's portfolio in Q3 2026, its #4109 holding.
  • Global Retirement Partners first reported a position in Tarsus Pharmaceuticals in Q3 2024 and has held it in 6 quarters since.
  • Global Retirement Partners's Tarsus Pharmaceuticals position peaked at $5.98K in Q4 2025.
  • 255 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Global Retirement Partners's 13F filing for Q3 2026, filed 10 Nov 2026.